Role of Vif in human immunodeficiency virus type 1 reverse transcription

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8701-8709

  Goncalves, Joao ^a   Korin, Yael ^b   Zack, Jerome ^b   Gabuzda, Dana ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; RNA DIRECTED DNA POLYMERASE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRION; VIRUS GENOME; VIRUS INHIBITION; VIRUS TRANSCRIPTION;

EID: 0029861076     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8701-8709.1996     Document Type: Article

References (44)

1. Benz, E. W., Jr., and D. Dina. 1979. Moloney murine sarcoma virions synthesize full-genome-length double-stranded DNA in vitro. Proc. Natl. Acad. Sci. USA 76:3294-3298.
2. Boone, L. R., and A. M. Skalka. 1981. Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. J. Virol. 37:109-116.
3. Borman, A. M., C. Quillet, P. Chameau, C. Dauguet, and F. Clavel. 1995. Human immunodeficiency virus type 1 Vif mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J. Virol. 69: 2058-2067.
4. Borroto-Esoda, K., and L. R. Boone. 1991. Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction. J. Virol. 65:1952-1959.
5. Camaur, D., and D. Trono. 1996. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol. 70:6106-6111.
6. Chameau, P., and F. Clavel. 1991. A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J. Virol. 65:2415-2421.
7. Courcoul, M., C. Patience, F. Rey, D. Blanc, A. Harmache, J. Sire, R. Vigne, and B. Spire. 1995. Peripheral blood mononuclear cells produce normal amounts of defective Vif human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J. Virol. 69:2068-2074.
8. Debyser, Z., A.-M. Vandamme, R. Pauwels, M. Baba, J. Desmyter, and E. De Clerq. 1992. Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcriptase by 2′,3′-dideoxynucleoside 5′-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thione, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives. J. Biol. Chem. 267: 11769-11776.
9. Fan, L., and K. Peden. 1992. Cell-free transmission of Vif mutants of HIV-1. Virology 190:19-29.
10. Fisher, A. G., B. Ensoli, L. Ivanoff, M. Chamberlain, S. Petteway, L. Ratner, R. C. Gallo, and F. Wong-Staal. 1987. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237:888-893.
11. Foley, G. E., H. Lazarus, J. Dredd, S. Faber, B. G. Uzn, B. Boone, and R. E. McCarthy. 1965. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18:522-529.
12. Fu, W., R. J. Gorelick, and A. Rein. 1994. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J. Virol. 68:5013-5018.
13. Fu, W., and A. Rein. 1993. Maturation of dimeric viral RNA of Moloney murine leukemia virus. J. Virol. 67:5443-5449.
14. + T lymphocytes. J. Virol. 66:6489-6495.
15. Gabuzda, D. H., H. Li, K. Lawrence, B. S. Vasir, K. Crawford, and E. Langhoff. 1994. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. J. Acquired Immune Defic. Syndr. 7:908-915.
16. Gilboa, E., S. Goff, A. Shields, F. Yoshimura, S. Mitra, and D. Baltimore. 1979. In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus. Cell 16:863-874.
17. Goncalves, J., and D. Gabuzda. Unpublished data.
18. Goncalves, J., P. Jallepalli, and D. H. Gabuzda. 1994. Subcellular localization of the Vif protein of human immunodeficiency virus type 1. J. Virol. 68:704-712.
19. Höglund, S., A. Ohagen, K. Lawrence, and D. Gabuzda. 1994. Role of vif during packing of the core of HIV-1. Virology 201:349-355.
20. Ji, X., G. J. Klarmann, and B. D. Preston. 1996. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro. Biochemistry 35:132-143.
21. Junghans, R. P., P. H. Duesberg, and C. A. Knight. 1975. In vitro synthesis of full-length DNA transcripts of Rous sarcoma virus RNA by viral DNA polymerase. Proc. Natl. Acad. Sci. USA 72:1895-1900.
22. Karczewski, M. K., and K. Strebel. 1996. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J. Virol. 70:494-507.
23. Khandjian, E. W., and C. Meric. 1986. A procedure for Northern blot analysis of native RNA. Anal. Biochem. 159:227-232.
24. Klarmann, G. J., C. A. Schauber, and B. D. Preston. 1993. Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequence in vitro. J. Biol. Chem. 268:9793-9802.
25. Lapadat-Tapolsky, M., H. De Rocquigny, D. V. Gent, B. Roques, R. Plasterk, and J.-L. Darlix. 1993. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res. 21:831-839.
26. Liu, H., X. Wu, M. Newman, G. M. Shaw, B. H. Hahn, and J. C. Kappes. 1995. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 69:7630-7638.
27. Miller, M. D., B. Wang, and F. D. Bushman. 1995. Human immunodeficiency virus type 1 preintegration complexes containing discontinuous plus strands are competent to integrate in vitro. J. Virol. 69:3938-3944.
28. Myers, G., S. F. Josephs, A. B. Rabson, T. I. Smith, and F. Wong-Staal (ed.). 1988. Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, N.Mex.
29. Peliska, J. A., and S. J. Benkovic. 1992. Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science 258:1112-1118.
30. Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, L. Ivanoff, S. R. Petleway, M. L. Pearson, J. A. Lautenberger, T. S. Papas, J. Ghrayeh, N. T. Chang, R. C. Gallo, and F. Wong-Staal. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (London) 313:277-284.
31. Rho, H. M., B. Poiesz, W. Ruscetti, and R. C. Gallo. 1981. Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line. Virology 112:355-360.
32. Rothenberg, E., D. Smotkin, D. Baltimore, and R. A. Weinberg. 1977. In vitro synthesis of infectious DNA of murine leukemia virus. Nature (London) 269:122-126.
33. Sakai, H., R. Shibata, J.-I. Sakuragi, S. Sakuragi, M. Kawamura, and A. Adachi. 1993. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67:1663-1666.
34. Simm, M., M. Shahbuddin, W. Chao, and D. J. Volsky. 1995. Aberrant Gag protein composition of human immunodeficiency virus type 1 (HIV-1) vif mutant produced in lymphocytes. J. Virol. 69:4582-4586.
35. Simon, J. H. M., and M. H. Malim. 1996. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol. 70:5297-5305.
36. Sodroski, J., W. C. Goh, C. Rosen, A. Tartar, D. Portetelle, A. Burny, and W. Haseltine. 1986. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science 231:1549-1551.
37. Sova, P., and D. Volsky. 1993. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J. Virol. 67:6322-6326.
38. Strebel, K., D. Daugherty, K. Clouse, D. Cohen, T. Folks, and M. A. Martin. 1987. The HIV "A" (sor) gene product is essential for virus infectivity. Nature (London) 328:728-730.
39. Tsuchihashi, Z., and P. O. Brown. 1994. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 68:5863-5870.
40. von Schwedler, U., J. Song, C. Aiken, and D. Trono. 1993 vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:4945-4955.
41. Weiss, S., G. Häusl, M. Famulok, and B. König. 1993. The multimerization state of retroviral RNA is modulated by ammonium ions and affects HIV-1 full-length cDNA synthesis in vitro. Nucleic Acids Res. 21:4879-4885.
42. Yong, W., H. S. Wyman, and J. A. Levy. 1990. Optimal conditions for synthesizing complementary DNA in the HIV-1 endogenous reverse transcriptase reaction. AIDS 4:199-206.
43. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
44. Zhang, H., Y. Zhang, T. P. Spicer, L. Z. Abbott, M. Abbott, and B. J. Poiesz. 1993. Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance. AIDS Res. Hum. Retroviruses 9:1287-1296.